GO:0007096 regulation of exit from mitosis: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007096 (regulation of exit from mitosis) describes the biological processes that drive the transition from anaphase/telophase to G1, coupled to a switch from high to low mitotic CDK activity.
• Mitotic exit is controlled by checkpoints and by the spatiotemporal regulation of the anaphase-promoting complex/cyclosome (APC/C), which targets mitotic cyclins for degradation.
• In budding yeast, the Cdc14 phosphatase and the mitotic exit network (MEN) are central to reversing CDK phosphorylation and licensing G1 entry.
• Exit from mitosis is not a simple switch: single-cell studies show that CDK2 activity bifurcates at mitotic exit, determining whether cells commit to proliferation or enter quiescence.
• Transcription factors are activated during the mitosis-to-G1 transition and shape the gene expression program that stabilizes the post-mitotic state.
• Deregulated mitotic exit is linked to chromosomal instability and cancer, making its regulators attractive targets for experimental modeling and therapeutic exploration.
Description
Regulation of exit from mitosis (GO:0007096) is the set of biological processes that govern the progression from anaphase/telophase to G1 and that are associated with a conversion from high to low mitotic CDK activity. This transition is essential for faithful cell division because it ensures that chromosomes are properly segregated and that the daughter cells reset their cycle for the next round of DNA replication. In budding yeast, exit from mitosis requires the inactivation of mitotic CDKs and the reversal of CDK-dependent phosphorylation, processes coordinated by the Cdc14 phosphatase and the mitotic exit network (MEN). In metazoans, the anaphase-promoting complex/cyclosome (APC/C) provides spatiotemporal control of mitotic cyclin degradation, which is a prerequisite for CDK inactivation and exit. Beyond a simple on/off switch, exit from mitosis is a decision point. Single-cell analysis of CDK2 activity has revealed a bifurcation at mitotic exit that determines whether a cell commits to another division or enters quiescence. This decision is reinforced by transcription factors that are activated during the mitosis-to-G1 transition and that establish the post-mitotic gene expression program. Because errors in this transition can lead to aneuploidy and genomic instability, understanding its regulation is central to cancer biology and to the development of targeted experimental models. This article synthesizes the authoritative QuickGO definition of GO:0007096 with real PubMed literature to provide a research-grade overview of the mechanisms, key genes, disease links, and experimental methods used to study regulation of exit from mitosis.
regulation of exit from mitosis At A Glance
| GO ID | GO:0007096 |
|---|---|
| GO term | regulation of exit from mitosis |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Progression from anaphase/telophase to G1 with conversion from high to low mitotic CDK activity |
| Key regulators | APC/C, Cdc14 phosphatase, mitotic exit network (MEN), CDK2 activity dynamics |
| Cellular context | Late mitosis (anaphase/telophase) to G1 transition |
| Research relevance | Cell cycle control, genomic stability, cancer, quiescence decision |
What Is GO:0007096?
GO:0007096 (regulation of exit from mitosis) is defined as any process involved in the progression from anaphase/telophase to G1 that is associated with a conversion from high to low mitotic CDK activity. In other words, it encompasses the signaling, enzymatic, and regulatory events that shut down mitotic CDK activity and allow cells to complete division and enter the next G1 phase.
Why Is regulation of exit from mitosis Important in Cell Biology?
Regulation of exit from mitosis is critical because it ensures that cell division is completed only after chromosomes are properly segregated and that daughter cells reset their cycle for future divisions. Failures in this process can lead to aneuploidy, genomic instability, and uncontrolled proliferation, which are hallmarks of cancer. Moreover, the decision to exit mitosis and either re-enter the cycle or become quiescent is controlled by a bifurcation in CDK2 activity, linking mitotic exit to long-term cell fate. Understanding GO:0007096 therefore has broad implications for developmental biology, cancer research, and regenerative medicine.
• Ensures faithful chromosome segregation and completion of cell division.
• Controls the switch from high to low mitotic CDK activity, a prerequisite for G1 entry.
• Determines whether cells proliferate or enter quiescence via CDK2 activity bifurcation.
• Coordinates the degradation of mitotic cyclins through APC/C spatiotemporal regulation.
• Involves the Cdc14 phosphatase and MEN in yeast, providing a paradigm for mitotic exit control.
• Activates transcription factors that establish the mitosis-to-G1 gene expression program.
• Deregulation is linked to chromosomal instability and cancer.
• Provides targets for experimental modeling of cell cycle and disease.
• Relevant to multinucleate cells, where a minimal gene network regulates exit from mitosis.
• Metabolic inputs such as lactate can influence mitosis, highlighting integration with cellular metabolism.
What Happens During regulation of exit from mitosis?
Inactivation of mitotic CDK activity
In simple terms: The cell turns off the main engine that drives mitosis.
Exit from mitosis requires a conversion from high to low mitotic CDK activity. This is achieved in part by the degradation of mitotic cyclins, which are the regulatory subunits of CDKs, through the ubiquitin-proteasome system. In budding yeast, the Cdc14 phosphatase reverses CDK-dependent phosphorylation, further promoting CDK inactivation and exit. The spatiotemporal regulation of APC/C ensures that cyclin degradation occurs at the right time and place during mitosis.
APC/C-mediated proteolysis
In simple terms: A molecular machine tags mitotic proteins for destruction.
The anaphase-promoting complex/cyclosome (APC/C) is a multi-subunit E3 ubiquitin ligase that targets securin and mitotic cyclins for degradation. Its activity is tightly regulated in space and time during mitosis, ensuring that sister chromatid separation and CDK inactivation occur in the correct order. APC/C activation is a hallmark of exit from mitosis and is conserved from yeast to humans.
Cdc14 phosphatase and the mitotic exit network (MEN)
In simple terms: A phosphatase and a signaling network team up to reverse mitotic modifications.
In Saccharomyces cerevisiae, the Cdc14 phosphatase is sequestered in the nucleolus during early mitosis and is released by the mitotic exit network (MEN) to dephosphorylate CDK substrates. This dephosphorylation is essential for exit from mitosis and for coupling exit to partitioning of the nucleus. The MEN is a GTPase-driven signaling cascade that coordinates Cdc14 release with spindle position and nuclear segregation.
Checkpoint control and fidelity
In simple terms: Safety checks ensure the cell doesn't exit mitosis prematurely.
Cell cycle checkpoints, including the spindle assembly checkpoint and the morphogenesis checkpoint, regulate mitotic exit to prevent premature or incorrect division. In budding yeast, these checkpoints delay exit from mitosis until spindle positioning and chromosome segregation are completed. This regulation is critical for genomic stability and is conserved in principle across eukaryotes.
Bifurcation of CDK2 activity and cell fate
In simple terms: After mitosis, cells decide whether to divide again or take a rest.
Single-cell studies have shown that CDK2 activity bifurcates at mitotic exit, with some cells maintaining high CDK2 activity and re-entering the cycle, while others drop to low activity and enter quiescence. This decision is influenced by the duration and dynamics of mitotic exit and by transcriptional programs activated during the mitosis-to-G1 transition. Thus, regulation of exit from mitosis is not only a mechanical process but also a cell fate decision point.
Transcriptional reprogramming at the mitosis-to-G1 transition
In simple terms: The cell changes which genes are turned on as it exits mitosis.
Transcription factors are activated during the mitosis-to-G1 transition and drive a gene expression program that supports G1 progression and cell fate. This transcriptional reprogramming is coordinated with CDK inactivation and APC/C activity to ensure a stable post-mitotic state. In multinucleate cells such as Ashbya gossypii, a minimal network of genes regulates exit from mitosis, highlighting the core conserved machinery.
Key Genes Involved in GO:0007096 regulation of exit from mitosis
The following genes and proteins are central to the regulation of exit from mitosis (GO:0007096) based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CDC14 | Phosphatase that reverses CDK phosphorylation; released from nucleolus during mitotic exit | Key effector of exit from mitosis in yeast; model for phosphatase-driven CDK inactivation |
| CDC15 | Kinase in the mitotic exit network (MEN) that promotes Cdc14 release | Central MEN component; target for studying checkpoint control of mitotic exit |
| TEM1 | GTPase that activates the MEN | Regulates Cdc14 release and exit from mitosis |
| CDC5 | Polo-like kinase in yeast that regulates MEN and mitotic exit | Conserved regulator of mitotic exit and cytokinesis |
| APC/C subunits (e.g., APC1, CDC16, CDC23) | E3 ubiquitin ligase that targets mitotic cyclins for degradation | Core machinery for proteolytic control of mitotic exit |
| CDH1 | Activator of APC/C that promotes cyclin degradation at mitotic exit | Regulates substrate specificity of APC/C during exit |
| CDC20 | Activator of APC/C that targets securin and cyclins early in mitosis | Essential for anaphase onset and mitotic exit |
| CLB2 (cyclin B) | Mitotic cyclin whose degradation is required for CDK inactivation | Key substrate of APC/C; marker of mitotic exit |
| CDK1 (CDC28 in yeast) | Mitotic CDK whose activity must drop for exit | Central kinase controlling mitosis; target of inactivation |
| CDK2 | CDK whose activity bifurcates at mitotic exit to determine proliferation vs quiescence | Single-cell marker of cell fate after mitosis |
| SPN1/2 (securin) | Separase inhibitor degraded by APC/C to allow sister chromatid separation | Links APC/C to chromosome segregation and exit |
| ESP1 (separase) | Protease that cleaves cohesin; regulated by securin | Coordinates chromosome segregation with mitotic exit |
| NET1 | Nucleolar anchor of Cdc14; regulated by MEN | Controls Cdc14 release and timing of exit |
| MOB1 | MEN component that regulates Cdc15 and Cdc14 | Part of the MEN signaling cascade |
| DBF2 | Kinase in MEN that phosphorylates Net1 | Promotes Cdc14 release |
| ASHBYA gossypii minimal network genes | Minimal set of genes sufficient for exit from mitosis in multinucleate cells | Model for core conserved machinery |
| Transcription factors (e.g., FOXM1, E2F) | Activated during mitosis-to-G1 transition to drive gene expression | Link mitotic exit to transcriptional reprogramming |
| Lactate-responsive metabolic genes | Metabolic inputs that can influence mitosis | Emerging link between metabolism and mitotic exit |
How Is regulation of exit from mitosis Regulated?
Regulation of exit from mitosis is controlled by multiple layers of regulation. Cell cycle checkpoints, such as the spindle assembly checkpoint and the morphogenesis checkpoint, delay exit until chromosome segregation and spindle positioning are completed. The APC/C is regulated by its activators Cdc20 and Cdh1, which determine substrate specificity and timing of cyclin degradation. In budding yeast, the mitotic exit network (MEN) is a GTPase-driven signaling cascade that controls the release of the Cdc14 phosphatase from the nucleolus. Additionally, metabolic inputs such as lactate can influence mitosis, suggesting integration with cellular metabolism. Finally, transcriptional programs activated during the mitosis-to-G1 transition reinforce the post-mitotic state.
regulation of exit from mitosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APC/C subunits | Cancer, chromosomal instability | Knockout or point-mutation cell lines to study mitotic exit defects |
| CDC14 | Cancer, cell cycle deregulation | Knockout yeast or human cell models to assess Cdc14 function |
| CDK2 | Cell fate, quiescence, cancer | Knock-in reporter for CDK2 activity to track bifurcation |
| CDC20 | Cancer, aneuploidy | Overexpression or knockout models to study APC/C activation |
| MEN components (CDC15, TEM1) | Fungal growth, cell cycle | Yeast knockout and point-mutation models |
Cancer and genomic instability
Deregulation of exit from mitosis can lead to chromosomal instability and aneuploidy, which are hallmarks of cancer. The APC/C and its regulators are frequently altered in tumors, and defects in mitotic exit checkpoints can promote tumorigenesis. Understanding GO:0007096 provides insights into how cancer cells evade normal cell cycle controls.
Cell fate and quiescence
The bifurcation of CDK2 activity at mitotic exit determines whether cells proliferate or enter quiescence. This decision is relevant to tissue homeostasis and regeneration, and its dysregulation may contribute to diseases characterized by abnormal cell proliferation or stem cell exhaustion.
Multinucleate cells and fungal pathogens
In multinucleate cells such as Ashbya gossypii, a minimal network of genes regulates exit from mitosis. This has implications for understanding fungal growth and pathogenicity, as well as for comparative cell cycle biology.
From regulation of exit from mitosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate exit from mitosis? | Knockout cell lines (e.g., CRISPR KO) followed by cell cycle analysis |
| How does a specific mutation affect mitotic exit? | Point-mutation knock-in models |
| What is the spatiotemporal dynamics of a regulator? | Tagged knock-in with fluorescent reporter |
| Does overexpression of gene Y alter mitotic exit? | Overexpression cell lines |
| What is the transcriptional program at mitosis-to-G1? | RNA-seq of synchronized cells |
| How does metabolism influence mitotic exit? | Metabolic perturbation with lactate or other fuels |
How to Study the regulation of exit from mitosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Dynamics of CDK activity, APC/C substrates, chromosome segregation | Tracking mitotic exit in single cells |
| Proteomics | Protein abundance and modifications | Identifying APC/C substrates and Cdc14 targets |
| Phosphoproteomics | Phosphorylation changes | Mapping CDK and Cdc14 substrate dephosphorylation |
| RNA-seq | Transcriptional changes | Characterizing mitosis-to-G1 gene expression |
| CRISPR knockout screen | Gene requirement for mitotic exit | Discovering novel regulators |
| CRISPR activation screen | Gene overexpression effects | Identifying drivers of mitotic exit |
| Flow cytometry | DNA content and cell cycle profile | Assessing exit from mitosis in populations |
| Yeast genetics | Genetic interactions and pathways | Dissecting MEN and Cdc14 regulation |
Live-cell imaging of mitotic exit
Live-cell imaging with fluorescent reporters for CDK activity, APC/C substrates, or chromosome segregation allows real-time monitoring of exit from mitosis. This method is essential for capturing the dynamics and bifurcation of CDK2 activity at mitotic exit.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can identify substrates of APC/C and Cdc14, as well as changes in phosphorylation status during mitotic exit. This provides a global view of the molecular events that define GO:0007096.
Transcriptomics (RNA-seq)
RNA-seq of synchronized cell populations can reveal the transcriptional programs activated during the mitosis-to-G1 transition. This helps identify transcription factors and gene networks that reinforce exit from mitosis.
Genetic screens and CRISPR libraries
CRISPR-based knockout or activation screens can systematically identify genes required for or capable of regulating exit from mitosis. Such screens are powerful for discovering novel regulators and disease targets.
How CRISPR Can Be Used to Study GO:0007096 regulation of exit from mitosis
Knockout
CRISPR knockout of genes such as CDC14, CDC15, or APC/C subunits can reveal their essential roles in exit from mitosis. Knockout cell lines are used to assess cell cycle arrest, chromosome segregation defects, and sensitivity to drugs.
Point Mutation
Point mutations in catalytic residues or regulatory phosphorylation sites of mitotic exit regulators can dissect their specific functions. For example, kinase-dead or phosphatase-dead mutants help distinguish catalytic from scaffolding roles.
Knock-in
Knock-in of fluorescent tags or epitope tags at endogenous loci allows real-time tracking of protein localization and dynamics during mitotic exit. This is particularly useful for studying Cdc14 release or APC/C activation.
Overexpression
Overexpression of mitotic exit regulators or their substrates can test sufficiency for driving or blocking exit. This approach is valuable for identifying dominant-negative or gain-of-function phenotypes.
How EDITGENE Supports regulation of exit from mitosis Research
Researchers studying regulation of exit from mitosis-related genes often need to determine whether a candidate gene is causally involved in the transition from anaphase/telophase to G1, and to dissect its mechanism of action. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of exit from mitosis research.
Frequently Asked Questions About regulation of exit from mitosis
What is GO:0007096 regulation of exit from mitosis?
GO:0007096 is a Gene Ontology biological process term defined as any process involved in the progression from anaphase/telophase to G1 that is associated with a conversion from high to low mitotic CDK activity.
What genes are involved in regulation of exit from mitosis?
Key genes include CDC14, CDC15, TEM1, CDC5, APC/C subunits, CDH1, CDC20, CLB2, CDK1, and CDK2, among others.
Why is exit from mitosis important?
It ensures faithful chromosome segregation and resets the cell cycle for G1 entry; its deregulation can cause aneuploidy and cancer.
How is exit from mitosis regulated?
It is regulated by checkpoints, APC/C-mediated proteolysis, the Cdc14 phosphatase, the mitotic exit network, and transcriptional programs.
What is the role of APC/C in mitotic exit?
APC/C is an E3 ubiquitin ligase that targets mitotic cyclins for degradation, leading to CDK inactivation and exit from mitosis.
What is the mitotic exit network (MEN)?
The MEN is a GTPase-driven signaling cascade in yeast that controls the release of the Cdc14 phosphatase from the nucleolus to promote exit from mitosis.
How does CDK2 activity relate to mitotic exit?
CDK2 activity bifurcates at mitotic exit, determining whether cells re-enter the cycle or become quiescent.
What diseases are linked to defects in exit from mitosis?
Cancer and genomic instability are linked to defects in mitotic exit regulation.
What methods are used to study regulation of exit from mitosis?
Live-cell imaging, proteomics, phosphoproteomics, RNA-seq, and CRISPR screens are commonly used.
How can CRISPR help study GO:0007096?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of gene function in mitotic exit.
Conclusion
Regulation of exit from mitosis (GO:0007096) is a fundamental biological process that ensures the proper completion of cell division and the transition to G1. It integrates checkpoint control, proteolysis, phosphatase activity, and transcriptional reprogramming to convert high mitotic CDK activity to low activity. Dysregulation of this process is linked to cancer and genomic instability, making it a critical area of research. EDITGENE provides comprehensive CRISPR-based services, including knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics, to support mechanistic and translational studies of GO:0007096. By leveraging these tools, researchers can uncover novel regulators and therapeutic targets with confidence.
References
- 1. Matellán L et al.. 2020. Regulation of Mitotic Exit by Cell Cycle Checkpoints: Lessons From Saccharomyces cerevisiae.. Genes (Basel) 11(2) PMID: 32059558
- 2. Soares MAF et al.. 2022. Function and regulation of transcription factors during mitosis-to-G1 transition.. Open Biol 12(6):220062 PMID: 35642493
- 3. Spencer SL et al.. 2013. The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit.. Cell 155(2):369-83 PMID: 24075009
- 4. Baro B et al.. 2017. Regulation of Mitotic Exit in Saccharomyces cerevisiae.. Methods Mol Biol 1505:3-17 PMID: 27826852
- 5. Bardin AJ et al.. 2000. A mechanism for coupling exit from mitosis to partitioning of the nucleus.. Cell 102(1):21-31 PMID: 10929710
- 6. Dai X et al.. 2023. Lactate fuels mitosis.. Mol Cell 83(10):1549-1551 PMID: 37207623
- 7. Finlayson MR et al.. 2011. Regulation of exit from mitosis in multinucleate Ashbya gossypii cells relies on a minimal network of genes.. Mol Biol Cell 22(17):3081-93 PMID: 21737675
- 8. Sivakumar S et al.. 2015. Spatiotemporal regulation of the anaphase-promoting complex in mitosis.. Nat Rev Mol Cell Biol 16(2):82-94 PMID: 25604195
